- Home
- ASRV vs INMB Comparison
ASRV vs INMB Comparison
Compare ASRV & INMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ASRV | INMB |
|---|---|---|
| Founded | 1983 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 78.4M | 64.7M |
| IPO Year | 1994 | 2018 |
Fundamental Metrics
Financial Performance| Metric | ASRV | INMB |
|---|---|---|
| Price | $4.74 | $1.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $5.40 |
| AVG Volume (30 Days) | 11.6K | ★ 308.0K |
| Earning Date | 04-21-2026 | 05-07-2026 |
| Dividend Yield | ★ 3.16% | N/A |
| EPS Growth | ★ 61.90 | 11.85 |
| EPS | ★ 0.27 | N/A |
| Revenue | ★ $14,634,000.00 | $50,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.04 | ★ N/A |
| Revenue Growth | N/A | ★ 257.14 |
| 52 Week Low | $2.86 | $1.09 |
| 52 Week High | $5.38 | $2.60 |
Technical Indicators
Market Signals| Indicator | ASRV | INMB |
|---|---|---|
| Relative Strength Index (RSI) | 50.13 | 41.37 |
| Support Level | $3.62 | $1.97 |
| Resistance Level | $5.09 | $2.51 |
| Average True Range (ATR) | 0.21 | 0.15 |
| MACD | -0.02 | -0.05 |
| Stochastic Oscillator | 42.19 | 7.69 |
Price Performance
Historical ComparisonAbout ASRV AmeriServ Financial Inc.
AmeriServ Financial Inc is a bank holding company. The company and its subsidiaries derive substantially all of their income from banking, bank-related services, and trust-related services. Its operating segment includes community banking and it generates maximum revenue. The community banking segment includes both retail and commercial banking activities. The company also offers retail banking which includes the deposit-gathering branch franchise and lending to both individuals and small businesses; Lending activities include residential mortgage loans, direct consumer loans, and small business commercial loans; Commercial banking to businesses includes commercial loans, business services, and CRE loans.
About INMB INmune Bio Inc.
INmune Bio Inc is a clinical stage biotechnology pharmaceutical company focused on developing and commercializing its product candidates to treat diseases where inflammation and immunology cause a dysfunctional immune system contributing to disease. The company's pipeline products include INKmune, XPro1595, and others. It has three product platforms; The CORDStrom product platform, The DN-TNF product platform, and The Natural Killer Cell Priming Platform.